Developing Multi-Specific Autologous T Cell Therapy Targeting Tumour Neoantigens
Time: 9:30 am
day: Day Two
Details:
- Understanding pokeAcell’s ImmPACT technology – Simple expansion of neoantigen-specific T cells directly from blood
- Exploring how AI-predicted neoantigens are utilised to generate a multi-specific polyclonal functional T cell product
